TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/30/04 17:00 | 4/28/04 | MEDI | Medimmune Inc /de | DE | Health | BioPrd | Biological Products, (No Diag | Booth Melvin D | MD | D | S.d | -11,567 | 25.70 | 0 | -450 | -96 | 20 | D | |||||||||||||||
10/14/03 16:56 | 10/13/03 | MEDI | Medimmune Inc /de | DE | Health | BioPrd | Biological Products, (No Diag | Booth Melvin D | MD | DO | P,COO | S | -3,331 | 33.31 | 0 | -100 | -83 | 20 | D | ||||||||||||||
9/12/03 16:52 | 9/12/03 | MEDI | Medimmune Inc /de | DE | Health | BioPrd | Biological Products, (No Diag | Booth Melvin D | MD | DO | P,COO | S | -3,727 | 37.27 | 0 | -100 | -83 | 20 | D | ||||||||||||||
8/14/03 14:23 | 8/12/03 | MEDI | Medimmune Inc /de | DE | Health | BioPrd | Biological Products, (No Diag | Booth Melvin D | MD | DO | P,COO | S | -3,635 | 36.35 | 0 | -100 | -83 | 20 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |